Complete molecular remission in a polycythaemia vera patient 12 years after discontinuation of interferon-alpha.
Issue Date
2011-02MeSH
HumansInterferon-alpha
Janus Kinase 2
Male
Mutation
Polycythemia Vera
Remission Induction
Treatment Outcome
Young Adult
Metadata
Show full item recordCitation
Complete molecular remission in a polycythaemia vera patient 12 years after discontinuation of interferon-alpha. 2011, 90 (2):233-4 Ann. Hematol.Journal
Annals of hematologyDOI
10.1007/s00277-010-0993-2PubMed ID
20512575Item Type
ArticleLanguage
enISSN
1432-0584ae974a485f413a2113503eed53cd6c53
10.1007/s00277-010-0993-2
Scopus Count
Collections
Related articles
- De novo polycythaemia vera arising 5 years following acute myeloid leukemia remission: suggestion of a chemotherapy resistant JAK2 clone.
- Authors: Portell CA, Sekeres MA, Rogers HJ, Tiu RV
- Issue date: 2012 Apr
- Hydroxyurea does not appreciably reduce JAK2 V617F allele burden in patients with polycythemia vera or essential thrombocythemia.
- Authors: Antonioli E, Carobbio A, Pieri L, Pancrazzi A, Guglielmelli P, Delaini F, Ponziani V, Bartalucci N, Tozzi L, Bosi A, Rambaldi A, Barbui T, Vannucchi AM
- Issue date: 2010 Aug
- Sustained major molecular response on interferon alpha-2b in two patients with polycythemia vera.
- Authors: Larsen TS, Bjerrum OW, Pallisgaard N, Andersen MT, Møller MB, Hasselbalch HC
- Issue date: 2008 Oct
- Decrease in JAK2 V617F allele burden is not a prerequisite to clinical response in patients with polycythemia vera.
- Authors: Kuriakose E, Vandris K, Wang YL, Chow W, Jones AV, Christos P, Cross NC, Silver RT
- Issue date: 2012 Apr
- Usefulness of JAK2V617F mutation in distinguishing idiopathic erythrocytosis from polycythemia vera.
- Authors: Rossi D, Cortini F, Deambrogi C, Barbieri C, Cerri M, Franceschetti S, Conconi A, Capello D, Gaidano G
- Issue date: 2007 Jan